Heska Announces Investor Day in New York City

LOVELAND, Colo., Nov. 4, 2014 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced the Company will conduct an Investor Day, from 9 a.m. to noon (EST) on Friday, November 14, 2014. The event will be at the Nasdaq MarketSite in Times Square, located at One Liberty Plaza, 165 Broadway, in New York City.

Availability for interested parties is extremely limited. Those interested in attending should contact [email protected]. For those unable to attend, the presentations are to be webcast and available through a link on the investor relations' portion of Heska's website.

Kevin Wilson, Heska's Chief Executive Officer and President, is to lead the discussion. In addition, Dr. Michael McGinley, President of Heska's Biologicals & Pharmaceuticals division, Jason Napolitano, Chief Financial Officer and Dr. Robert Grieve, Executive Chair, are to present and be available for a question and answer session.

About Heska

Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.  The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.   

SOURCE Heska Corporation

Related Links

http://www.heska.com